The Effect of the Degree of Deacetylation of Chitosan Nanoparticles and its Characterization and Encapsulation Efficiency on Drug Delivery

被引:28
作者
Yang, Hui-Chia [1 ]
Hon, Min-Hsiung [1 ]
机构
[1] Natl Cheng Kung Univ, Dept Mat Sci & Engn, Tainan 701, Taiwan
关键词
Chitosan; Degree of deacetylation; Fluorouracil; Nanoparticle; CONTROLLED-RELEASE; POLYELECTROLYTE COMPLEX; COLORECTAL-CANCER; BEADS; 5-FU; MICROSPHERES; INFUSION;
D O I
10.1080/03602559.2010.482076
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
In this study, we investigated the effects of the degree of deacetylation (DD) of chitosan on the resulting nanoparticles' properties. The diameters of the nanoparticles increased as the DD of chitosan decreased. In addition, we prepared fluorouracil-loaded chitosan nanoparticles and characterized them using FTIR and NMR spectroscopy. The encapsulation efficiency increased with the DD of chitosan. Particles produced using 90%-DD chitosan had a mean particle size of 113nm and a 56.5% drug loading. The stable nanoparticles formed through the complexation of chitosan with TPP have the potential for use in drug delivery.
引用
收藏
页码:1292 / 1296
页数:5
相关论文
共 24 条
  • [1] Recent advances on chitosan-based micro- and nanoparticles in drug delivery
    Agnihotri, SA
    Mallikarjuna, NN
    Aminabhavi, TM
    [J]. JOURNAL OF CONTROLLED RELEASE, 2004, 100 (01) : 5 - 28
  • [2] Alternative approach to the preparation of chitosan beads
    Aral, C
    Akbuga, J
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 168 (01) : 9 - 15
  • [3] Chitosan beads for the delivery of salmon calcitonin: Preparation and release characteristics
    Aydin, Z
    Akbuga, J
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 131 (01) : 101 - 103
  • [4] Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres
    Blanco, MD
    Alonso, MJ
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1997, 43 (03) : 287 - 294
  • [5] Chitosan nanoparticles for plasmid DNA delivery: Effect of chitosan molecular structure on formulation and release characteristics
    Bozkir, A
    Saka, OM
    [J]. DRUG DELIVERY, 2004, 11 (02) : 107 - 112
  • [6] Bozkir Asuman, 2005, Farmaco (Lausanne), V60, P840, DOI 10.1016/j.farmac.2005.06.016
  • [7] CABALLERO GA, 1985, CANCER TREAT REP, V69, P13
  • [8] Chitosan and chitosan ethylene oxide propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines
    Calvo, P
    RemunanLopez, C
    VilaJato, JL
    Alonso, MJ
    [J]. PHARMACEUTICAL RESEARCH, 1997, 14 (10) : 1431 - 1436
  • [9] FLENTJE M, 1986, CANCER CHEMOTH PHARM, V18, P223
  • [10] ENHANCED HEPATIC-UPTAKE OF LIPOSOMES THROUGH COMPLEMENT ACTIVATION DEPENDING ON THE SIZE OF LIPOSOMES
    HARASHIMA, H
    SAKATA, K
    FUNATO, K
    KIWADA, H
    [J]. PHARMACEUTICAL RESEARCH, 1994, 11 (03) : 402 - 406